Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment
| Title: | Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment |
|---|---|
| Authors: | Scheuring, U JAff1, ID2403062_cor1; Pfeifer, HAff1; Wassmann, BAff1; Brück, PAff1; Gehrke, BAff1; Petershofen, E KAff2; Gschaidmeier, HAff3; Hoelzer, DAff1; Ottmann, O GAff1 |
| Source: | Leukemia. 17(9):1700-1706 |
| Database: | Springer Nature Journals |